U.S. FOOD AND DRUG ADMINISTRATION: The Breakthrough Therapy Designation
For two decades, CDER has used certain methods to speed drug development and the regulatory review process so that promising therapies can get to patients faster.
For two decades, CDER has used certain methods to speed drug development and the regulatory review process so that promising therapies can get to patients faster.
Drug shortages have a significant impact on both hospitals and patients.
An audio podcast series featuring the Director of FDA Center for Drug Evaluation and Research